Bayer Eylea approved in Japan for treatment of preterm infants with retinopathy of prematurity Ruchika Sharma28 Sept 2022 11:34 AM ISTRetinopathy of prematurity is a rare eye disease that affects the vessels in the retina of premature infants and is the leading cause of visual...
Bayer unveils chronic heart failure treatment Vericiguat in India Ruchika Sharma27 Sept 2022 3:15 PM ISTChronic heart failure occurs when the heart is not able to pump blood as well as it should.
Bayer, Regeneron anti-blindness drug Eylea shown to work at higher dose, longer intervals Ruchika Sharma11 Sept 2022 9:00 AM ISTFrankfurt: Bayer said on Thursday that its anti-blindness treatment Eylea, jointly developed with Regeneron, was shown to work as well when given...
Bayer to pay USD 40 million to resolve US whistleblower claims over three drugs Ruchika Sharma4 Sept 2022 3:15 PM ISTNew Delhi: Bayer AG agreed to pay $40 million to settle claims over its alleged use of kickbacks and false statements related to three prescription...
Bayer unveils drug for CKD associated with diabetes under brand name Kerendia Ruchika Sharma26 Aug 2022 11:15 AM ISTThe major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end stage renal disease or kidney failure.
Bayer Mirena gets USFDA nod for extended use as contraceptive Ruchika Sharma21 Aug 2022 1:15 PM ISTLNG-IUS is one of the most effective birth control methods as it does not require user interventions such as daily dosing or monthly re-fills.
Bayer gets USFDA nod for Darolutamide, Docetaxel combo to treat metastatic hormone-sensitive prostate cancer Ruchika Sharma10 Aug 2022 3:00 PM ISTDarolutamide is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.
Arbitration ruling over BASF claims is imminent: Bayer Ruchika Sharma7 Aug 2022 1:30 PM ISTFrankfurt: Bayer's chief executive said an arbitration court would soon decide on claims brought by rival BASF, saying it overpaid for assets...
Bayer to sell Nebido to Grünenthal for over Rs 4051 crore Medical Dialogues Bureau18 July 2022 1:30 PM ISTBerlin: Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido (testosterone...
Drugmaker Orion sees inflation hit in H2 after quarterly profit beat Ruchika Sharma17 July 2022 9:00 AM ISTNew Delhi: Finnish drugmaker Orion on Friday reported better-than-expected quarterly earnings helped by strong sales of prostate cancer treatment...
'Golden time for India to emerge as innovator nation in biopharma sector' Ruchika Sharma23 Jun 2022 3:30 PM ISTWashington: Post COVID19, it's a golden time for India to emerge as an innovator nation in the biopharma sector, organiser of the annual India-US...
Bayer wins fourth Roundup weedkiller case in US Ruchika Sharma19 Jun 2022 4:00 PM ISTFrankfurt: A U.S. jury found Bayer's Roundup weedkiller did not cause an Oregon man's cancer, the German agriculture and pharmaceuticals company said...
